Abstract

In the title compound, C31H24Cl2N2S2, the pyrazole ring adopts planar conformation with a maximum deviation of 0.002 (2) Å. The chloro­phenyl rings are twisted out of the plane of the pyrazole ring by 75.1 (1) and 39.5 (1)°. The crystal packing is controlled by weak intermolecular C—H⋯π interactions.

Highlights

  • In the title compound, C31H24Cl2N2S2, the pyrazole ring adopts planar conformation with a maximum deviation of 0.002 (2) A

  • The crystal packing is controlled by weak intermolecular C—HÁ Á Á interactions

  • Cg3 and Cg5 are the centroids of the C14–C19 and C26–C31 rings, respectively

Read more

Summary

Structure Reports Online

Key indicators: single-crystal X-ray study; T = 293 K; mean (C–C) = 0.003 A; R factor = 0.052; wR factor = 0.160; data-to-parameter ratio = 29.3. C31H24Cl2N2S2, the pyrazole ring adopts planar conformation with a maximum deviation of 0.002 (2) A. The chlorophenyl rings are twisted out of the plane of the pyrazole ring by 75.1 (1) and 39.5 (1). Related literature For the pharmacological and medicinal properties of pyrazole derivatives, see: Baraldi et al (1998); Bruno et al (1990); Cottineau et al (2002); Londershausen (1996); Chen & Li (1998); Mishra et al (1998); Smith et al (2001). For bond-length data, see: Jin et al (2004)

Bruker Kappa APEXII diffractometer
DÁ Á ÁA
Special details
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.